The IARPA Pursuing Intelligent Complex Aerosols for Rapid Detection (PICARD) program will host a Proposer's Day on 26 September 2022 to introduce the PICARD program to potential proposers and to provide information on technical requirements and program objectives. The PICARD program intends to develop a fieldable sensing platform for the rapid identification of aerosol particles
The goal of the Global Bioequivalence Harmonization Initiative (GBHI) conference is to offer the most informative and up to date science and regulation of bioequivalence in global drug development. The FDA AAPS EUFEPS 5th Annual GBHI Meeting will be held 28-29 September 2022. GBHI workshop provides an open forum for pharmaceutical scientists from academia, industry
NDIA’s Business Institute and Carnegie Mellon University’s Software Engineering Institute will host a Managing for Supply Chain Resilience Course from 29-30 September 2022 to will explore the sources and types of supply chain risks and provide practical guidance on how to manage these in alignment with business strategy. The course includes an examination of prominent
The next public meeting of the National Biodefense Science Board (NBSB) will take place on Thursday, September 29. Join NBSB members, distinguished guests, federal leaders, and subject matter experts exploring topics such as how best to support rural and underserved communities during the COVID-19 pandemic, use of virtual healthcare during disasters, and health system operational
Experts and stakeholders in aerosol science of infectious diseases and indoor air quality will gather in North Carolina this October. The 40th AAAR Annual Conference of the American Association for Aerosol Research will take place 3-7 October 2022 in Raleigh, North Carolina. Special Symposia designed to bridge multiple areas and promote cross-disciplinary interaction will be held
The 2022 ESCMID/ASM Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance is scheduled to take place Oct. 4-7, 2022 in Dublin, Ireland. Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American
FDA's Center for Biologics Evaluation and Research (CBER) will host a free virtual format workshop on 5 October 2022 entitled Study Data Standards Update for CBER: Your Guide to a Successful Submission. CBER will discuss CBER’s support and requirement starting March 15, 2023 for the Standard for the Exchange of Nonclinical Data (SEND) , which
The FDA Vaccines and Related Biological Products Advisory Committee will convene on 6 October 2022 in open session to discuss the Strain Selection for the Influenza Virus Vaccines for the 2023 Southern Hemisphere Influenza Season. Materials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. Interested
The FDA NanoDay Symposium 2022 will be held on 11 October 2022. The event will address drug development of products that contain nanomaterials in their formulation and how the newly finalized guidance to industry for products that contain nanomaterials can be implemented in filings to the FDA. Highlighted topic areas include: Primary Chemistry Manufacturing and
